Skip to main content
Erschienen in: High Blood Pressure & Cardiovascular Prevention 5/2023

22.08.2023 | Original article

Trends in Serum Total Cholesterol and High Total Cholesterol Prevalence Among Royal Thai Army Personnel in Thailand, 2017–2022

verfasst von: Boonsub Sakboonyarat, Jaturon Poovieng, Kanlaya Jongcherdchootrakul, Phutsapong Srisawat, Panadda Hatthachote, Mathirut Mungthin, Ram Rangsin

Erschienen in: High Blood Pressure & Cardiovascular Prevention | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

High total cholesterol (TC) is a robust-documented risk factor for atherosclerosis cardiovascular diseases. Approximately one-fourth (23.5%) of Thai civilians had high TC. However, the information on high TC among the Royal Thai Army (RTA) personnel is limited.

Aim

The study aimed to identify the trends in serum TC and high TC prevalence among RTA personnel from 2017 to 2022.

Methods

A serial cross-sectional study from 2017 to 2022 was conducted. A total of 318,353 active-duty RTA personnel aged 35–60 years were included in the study. High TC was defined as fasting TC ≥ 240 mg/dL. A multivariable log-binomial regression analysis was performed to investigate factors associated with high TC.

Results

The overall age- and sex-adjusted high TC prevalence was 26.3% in 2017 and dropped to 22.9% in 2020; then, it increased to 26.4% in 2022 (p for quadratic trend < 0.001). Younger-aged RTA personnel have significantly rising trends in sex-adjusted high TC prevalence over 6 years. In the south, the age- and sex-adjusted high TC prevalence was 24.4% in 2017 and substantially rose to 33.6% in 2022 (p for quadratic trend < 0.001). Meanwhile, in the northeast, it rose by 3.6% over 6 years. High body mass index, high blood pressure, and hyperglycemia were associated with high TC prevalence among this population.

Conclusion

High TC was a common essential health issue among RTA personnel. Rising trends in mean serum TC and high TC prevalence from 2017 to 2022 were discovered, especially in younger participants and those residing in the south and northeast.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Liu X, Yan L, Xue F. The associations of lipids and lipid ratios with stroke: a prospective cohort study. J Clin Hypertens. 2019;21:127–35. Liu X, Yan L, Xue F. The associations of lipids and lipid ratios with stroke: a prospective cohort study. J Clin Hypertens. 2019;21:127–35.
2.
Zurück zum Zitat Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, the risk of stroke middle-aged British men. Stroke. 2000;31:1882–8.CrossRefPubMed Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, the risk of stroke middle-aged British men. Stroke. 2000;31:1882–8.CrossRefPubMed
3.
Zurück zum Zitat Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P. Serum cholesterol distribution and coronary heart disease risk. Circulation. 1998;97:1087–94.CrossRefPubMed Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P. Serum cholesterol distribution and coronary heart disease risk. Circulation. 1998;97:1087–94.CrossRefPubMed
4.
Zurück zum Zitat Peters SAE, Singhateh Y, Mackay D, Huxley RR, Woodward M. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis. 2016;248:123–31. Peters SAE, Singhateh Y, Mackay D, Huxley RR, Woodward M. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis. 2016;248:123–31.
5.
Zurück zum Zitat Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93–621. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93–621.
8.
Zurück zum Zitat Baygi F, Herttua K, Jensen OC, Djalalinia S, Mahdavi Ghorabi A, Asayesh H, et al. Global prevalence of cardiometabolic risk factors in the military population: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20:1–17. Baygi F, Herttua K, Jensen OC, Djalalinia S, Mahdavi Ghorabi A, Asayesh H, et al. Global prevalence of cardiometabolic risk factors in the military population: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20:1–17.
9.
Zurück zum Zitat Sakboonyarat B. Rising trends in the predicted 10-year risk of cardiovascular diseases among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2023;13:1476.CrossRef Sakboonyarat B. Rising trends in the predicted 10-year risk of cardiovascular diseases among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2023;13:1476.CrossRef
10.
Zurück zum Zitat Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Rising trends in obesity prevalence among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2022;12:7726. Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Rising trends in obesity prevalence among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2022;12:7726.
11.
Zurück zum Zitat Sakboonyarat B, Poovieng J, Srisawat P, Hatthachote P, Mungthin M, Rangsin R, et al. Prevalence, awareness, and control of hypertension and associated factors among Royal Thai Army personnel in Thailand from 2017 to 2021. Sci Rep. 2023;13:6946. CrossRefPubMedPubMedCentral Sakboonyarat B, Poovieng J, Srisawat P, Hatthachote P, Mungthin M, Rangsin R, et al. Prevalence, awareness, and control of hypertension and associated factors among Royal Thai Army personnel in Thailand from 2017 to 2021. Sci Rep. 2023;13:6946. CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021. BMC Public Health. 2022;22:1569.CrossRefPubMedPubMedCentral Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021. BMC Public Health. 2022;22:1569.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. J Med Assoc Thai. 2021;104:1729–38.CrossRef Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. J Med Assoc Thai. 2021;104:1729–38.CrossRef
14.
Zurück zum Zitat Daniel WW. Biostatistics: a foundation for analysis in the health sciences. Biometrics. 1995;51:386.CrossRef Daniel WW. Biostatistics: a foundation for analysis in the health sciences. Biometrics. 1995;51:386.CrossRef
15.
Zurück zum Zitat American Diabetes Association. Executive summary: standards of medical care in diabetes—2012. Diabetes Care. 2012;35(Suppl):1. American Diabetes Association. Executive summary: standards of medical care in diabetes—2012. Diabetes Care. 2012;35(Suppl):1.
16.
Zurück zum Zitat Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid AK, et al. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd.; 2000. Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid AK, et al. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd.; 2000.
17.
Zurück zum Zitat Sweeney JP, WeBirauch JL. Summary of available data for cholesterol in foods and methods for its determination. Crit Rev Food Sci Nutr. 1976;8:131–59.CrossRef Sweeney JP, WeBirauch JL. Summary of available data for cholesterol in foods and methods for its determination. Crit Rev Food Sci Nutr. 1976;8:131–59.CrossRef
18.
Zurück zum Zitat Carson JAS, Lichtenstein AH, Anderson CAM, Appel LJ, Kris-Etherton PM, Meyer KA, et al. Dietary cholesterol and cardiovascular risk: a science advisory from the American heart association. Circulation. 2020;141(3):e39–e53. Carson JAS, Lichtenstein AH, Anderson CAM, Appel LJ, Kris-Etherton PM, Meyer KA, et al. Dietary cholesterol and cardiovascular risk: a science advisory from the American heart association. Circulation. 2020;141(3):e39–e53.
19.
Zurück zum Zitat Afolabi WAO, Oyawoye OO, Sanni SA, Onabanjo OO. Proximate and cholesterol composition of selected fast foods sold in Nigeria. Niger Food J. 2013;31:70–6.CrossRef Afolabi WAO, Oyawoye OO, Sanni SA, Onabanjo OO. Proximate and cholesterol composition of selected fast foods sold in Nigeria. Niger Food J. 2013;31:70–6.CrossRef
21.
Zurück zum Zitat Sakboonyarat B, Rangsin R, Mittleman MA. Incidence and risk factors of metabolic syndrome among Royal Thai Army personnel. Sci Rep. 2022;12:1–11.CrossRef Sakboonyarat B, Rangsin R, Mittleman MA. Incidence and risk factors of metabolic syndrome among Royal Thai Army personnel. Sci Rep. 2022;12:1–11.CrossRef
22.
Zurück zum Zitat Sangbangmud J, Kaewthanasin B, Jintabunyat K, Pokabarl C, Limcharoenchai C, Kanchana-Udomkan N, et al. Incidence and risk factors of metabolic syndrome and 9-year follow-up in Na Yao Community, Sanam Chai Khet District, Chacheongsao, Thailand. J Southeast Asian Med Res. 2018;2:7–15.CrossRef Sangbangmud J, Kaewthanasin B, Jintabunyat K, Pokabarl C, Limcharoenchai C, Kanchana-Udomkan N, et al. Incidence and risk factors of metabolic syndrome and 9-year follow-up in Na Yao Community, Sanam Chai Khet District, Chacheongsao, Thailand. J Southeast Asian Med Res. 2018;2:7–15.CrossRef
23.
Zurück zum Zitat Haruyama Y, Nakagawa A, Kato K, Motoi M, Sairenchi T, Umesawa M, et al. Incidence of metabolic syndrome in young japanese adults in a 6-year cohort study: the Uguisudani Preventive Health Large-Scale cohort study (uphls). J Epidemiol. 2020;30:219–26.CrossRefPubMedPubMedCentral Haruyama Y, Nakagawa A, Kato K, Motoi M, Sairenchi T, Umesawa M, et al. Incidence of metabolic syndrome in young japanese adults in a 6-year cohort study: the Uguisudani Preventive Health Large-Scale cohort study (uphls). J Epidemiol. 2020;30:219–26.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Shang P, Shu Z, Wang Y, Li N, Du S, Sun F, et al. Veganism does not reduce the risk of the metabolic syndrome in a taiwanese cohort. Asia Pac J Clin Nutr. 2011;20:401–10. Shang P, Shu Z, Wang Y, Li N, Du S, Sun F, et al. Veganism does not reduce the risk of the metabolic syndrome in a taiwanese cohort. Asia Pac J Clin Nutr. 2011;20:401–10.
25.
Zurück zum Zitat Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44:211–21. Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44:211–21.
27.
Zurück zum Zitat Diabetes Association of Thailand under The Patronage of Her Royal Highness Princess Maha Chakri Sirindhorn, Endocrine Society of Thailand, Department of Medical Services M of PH, Office NHS. Clinical Practice Guideline for Diabetes 2017. Bangkok, Thailand; 2017. Diabetes Association of Thailand under The Patronage of Her Royal Highness Princess Maha Chakri Sirindhorn, Endocrine Society of Thailand, Department of Medical Services M of PH, Office NHS. Clinical Practice Guideline for Diabetes 2017. Bangkok, Thailand; 2017.
28.
Zurück zum Zitat Kim HL, Chung J, Kim KJ, Kim HJ, Seo WW, Jeon KH, et al. Lifestyle modification in the management of metabolic syndrome: statement from Korean Society of CardioMetabolic Syndrome (KSCMS). Korean Circ J. 2022;52:93–109.CrossRefPubMed Kim HL, Chung J, Kim KJ, Kim HJ, Seo WW, Jeon KH, et al. Lifestyle modification in the management of metabolic syndrome: statement from Korean Society of CardioMetabolic Syndrome (KSCMS). Korean Circ J. 2022;52:93–109.CrossRefPubMed
29.
Zurück zum Zitat Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC, Yusuf S, Zanchetti A, et al. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data. PLoS Med. 2018;15:e1002538.CrossRefPubMedPubMedCentral Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC, Yusuf S, Zanchetti A, et al. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data. PLoS Med. 2018;15:e1002538.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015;3:339–55.CrossRefPubMedPubMedCentral Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015;3:339–55.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Guideline CG181 N. Cardiovascular disease: risk assessment and reduction, including lipid modification. Methods. 2023. Guideline CG181 N. Cardiovascular disease: risk assessment and reduction, including lipid modification. Methods. 2023.
Metadaten
Titel
Trends in Serum Total Cholesterol and High Total Cholesterol Prevalence Among Royal Thai Army Personnel in Thailand, 2017–2022
verfasst von
Boonsub Sakboonyarat
Jaturon Poovieng
Kanlaya Jongcherdchootrakul
Phutsapong Srisawat
Panadda Hatthachote
Mathirut Mungthin
Ram Rangsin
Publikationsdatum
22.08.2023
Verlag
Springer International Publishing
Erschienen in
High Blood Pressure & Cardiovascular Prevention / Ausgabe 5/2023
Print ISSN: 1120-9879
Elektronische ISSN: 1179-1985
DOI
https://doi.org/10.1007/s40292-023-00596-z

Weitere Artikel der Ausgabe 5/2023

High Blood Pressure & Cardiovascular Prevention 5/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.